Sitravatinib as a potent FLT3 inhibitor can overcome gilteritinib resistance in acute myeloid leukemia

被引：0
|
作者：
Yvyin Zhang
Peihong Wang
Yang Wang
Yang Shen
机构：
[1] State Key Laboratory of Medical Genomics,Shanghai Institute of Hematology
[2] National Research Center for Translational Medicine (Shanghai),Department of Hematology
[3] Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,undefined
[4] Guangzhou First People’s Hospital,undefined
[5] School of Medicine,undefined
[6] South China University of Technology,undefined
来源：
Biomarker Research | / 11卷
关键词：
Sitravatinib; -ITD; AML; Gilteritinib; Drug resistance; -ITD-F691L; FL; FGF2;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Antitumor activity of the potent and novel FLT3 inhibitor HM43239 in acute myeloid leukemia
    Lee, Miyoung
    Ha, Young Eun
    Moon, Mi Jin
    Byun, Joo-Yun
    Yu, HyunKyung
    Kang, SeokJong
    Lee, Jaeho
    Lee, Kyuhang
    Kim, Eunkyung
    Kim, Eunyoung
    Lee, Ho Jeong
    Kim, YoungHoon
    Ahn, YoungGil
    Suh, KweeHyun
    Kim, Sun-Jin
    CANCER RESEARCH, 2018, 78 (13)
  • [32] Ningetinib, a novel FLT3 inhibitor, overcomes secondary drug resistance in acute myeloid leukemia
    Hu, Chuhong
    Zhang, Yvyin
    Yang, Jie
    Xu, Yanli
    Deng, Tingfen
    Li, Yumiao
    Xu, Shilin
    Wang, Shunqing
    Wang, Peihong
    CELL COMMUNICATION AND SIGNALING, 2024, 22 (01)
  • [33] The MERTK/FLT3 inhibitor MRX-2843 overcomes resistance-conferring FLT3 mutations in acute myeloid leukemia
    Minson, Katherine A.
    Smith, Catherine C.
    DeRyckere, Deborah
    Libbrecht, Clara
    Lee-Sherick, Alisa B.
    Huey, Madeline G.
    Lasater, Elisabeth A.
    Kirkpatrick, Gregory D.
    Stashko, Michael A.
    Zhang, Weihe
    Jordan, Craig T.
    Kireev, Dmitri
    Wang, Xiaodong
    Frye, Stephen V.
    Earp, H. Shelton
    Shah, Neil P.
    Graham, Douglas K.
    JCI INSIGHT, 2016, 1 (03)
  • [34] GNF-7, a novel FLT3 inhibitor, overcomes drug resistance for the treatment of FLT3‑ITD acute myeloid leukemia
    Xinhua Xiao
    Peihong Wang
    Weina Zhang
    Jiayi Wang
    Mansi Cai
    Hua Jiang
    Yingli Wu
    Huizhuang Shan
    Cancer Cell International, 23
  • [35] HM43239, a novel FLT3 inhibitor in overcoming resistance for acute myeloid leukemia
    Kim, JiSook
    Bae, InHwan
    Choi, JaeYul
    Kim, MinJeong
    Byun, JooYun
    Moon, Mijin
    Lee, EunYoung
    Kim, Yu-Yon
    Kang, Hyun Jeong
    Kim, Eunyoung
    Jung, SunYoung
    Ahn, YoungGil
    Kim, YoungHoon
    Suh, Kwee Hyun
    CANCER RESEARCH, 2019, 79 (13)
  • [36] Gilteritinib (ASP2215), a Novel FLT3/AXL Inhibitor: Preclinical Evaluation in Combination with Azacitidine in Acute Myeloid Leukemia
    Ueno, Yoko
    Mori, Masamichi
    Kamiyama, Yoshiteru
    Kaneko, Naoki
    Isshiki, Eriko
    Takeuchi, Masahiro
    BLOOD, 2016, 128 (22)
  • [37] Optimizing FLT3 Inhibitor Use in Adult Acute Myeloid Leukemia with FLT3 Mutations Using Proteomics
    Magalhaes, Eduardo Sabino
    Hubner, Stefan
    Brown, Brandon D.
    Qiu, Yihua
    Kornblau, Steven M.
    BLOOD, 2023, 142
  • [38] FLT3 Inhibition in Acute Myeloid Leukemia
    Smith, Catherine C.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S5 - S6
  • [39] FLT3 inhibitors in acute myeloid leukemia
    Wu, Mei
    Li, Chuntuan
    Zhu, Xiongpeng
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [40] FLT3 Inhibitors in Acute Myeloid Leukemia
    Stone, Richard M.
    ONCOLOGIST, 2016, 21 : S2 - S2
12345